Greenlight Capital Re (GLRE) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Company overview and business model
Operates as a global specialty property and casualty reinsurer, headquartered in the Cayman Islands, with principal operations through Greenlight Reinsurance, Ltd. (Cayman Islands), Greenlight Reinsurance Ireland DAC, and Lloyd's platform Syndicate 3456, focusing on multi-line and specialty reinsurance and insurtech partnerships.
Strategic investments are made in early-stage insurance companies and managing general agents to complement core reinsurance activities and strengthen client relationships.
The company’s ordinary shares are listed on the Nasdaq Global Select Market under the symbol “GLRE.”
Maintains a strong financial strength rating of A- (Excellent) from A.M. Best for its principal operating subsidiaries, with additional high ratings for its Lloyd’s syndicate.
Financial performance and metrics
As of June 15, 2024, 35,321,144 ordinary shares were issued and outstanding, with no preferred shares outstanding.
No share repurchases occurred during 2023 or Q1 2024 under the current $25 million repurchase plan expiring June 30, 2025.
2,914,198 ordinary shares remained available for future issuance under the company’s stock incentive plan as of March 31, 2024.
Outstanding options to purchase 902,140 ordinary shares and restricted share units convertible into 573,086 ordinary shares as of March 31, 2024.
Use of proceeds and capital allocation
Net proceeds from securities sales will be used for working capital, capital expenditures, acquisitions, and other general corporate purposes; may also be used for short-term investments or to reduce short-term borrowings.
Latest events from Greenlight Capital Re
- Record underwriting and investment gains fueled double-digit book value growth in 2025.GLRE
Q4 202513 Mar 2026 - Premiums up 9.1% but net income fell on storm losses and lower investment returns.GLRE
Q2 20242 Feb 2026 - Q3 net income surged to $35.2M, book value per share rose, but underwriting margins narrowed.GLRE
Q3 202416 Jan 2026 - Profitability, innovation, and diversification drive sustained growth and reduced risk.GLRE
Investor Day 202413 Jan 2026 - Q4 loss from CAT and aviation reserves, but 2024 ended with higher book value and net income.GLRE
Q4 202426 Dec 2025 - Registering up to $200M in securities to fund growth, leveraging Lloyd’s access and strong ratings.GLRE
Registration Filing16 Dec 2025 - Global specialty reinsurer seeks to raise up to $200 million via a flexible shelf registration.GLRE
Registration Filing16 Dec 2025 - Annual meeting to elect directors, ratify auditors, and approve executive pay amid strong 2024 results.GLRE
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, auditor ratification, and executive pay July 29, 2025.GLRE
Proxy Filing2 Dec 2025